May 18, 2026 05:08AM
May 18, 2026 03:00AM
May 7, 2026 07:02AM
May 7, 2026 07:00AM
Apr 1, 2026 08:04AM
Apr 1, 2026 08:02AM
Mar 26, 2026 08:00AM Quantum BioPharma names principal investigator for multiple sclerosis trial
Mar 26, 2026 08:00AM
Dec 23, 2025 08:02AM
Dec 23, 2025 08:00AM
Nov 7, 2025 07:00AM
Oct 23, 2025 08:15AM
Oct 2, 2025 07:57AM
Oct 2, 2025 07:57AM Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial
Sep 29, 2025 07:44AM
Sep 29, 2025 07:40AM
Aug 21, 2025 07:00AM
Aug 11, 2025 07:40AM
Aug 11, 2025 07:40AM
Aug 7, 2025 07:01AM
Aug 7, 2025 07:00AM Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during
Aug 5, 2025 07:34AM
Aug 5, 2025 07:34AM
Jun 18, 2025 09:19AM
May 20, 2025 07:31AM
May 20, 2025 07:30AM
May 12, 2025 08:04AM
May 12, 2025 08:00AM Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis
Mar 28, 2025 09:16AM
Mar 28, 2025 09:15AM
Mar 28, 2025 04:30AM
Mar 26, 2025 07:00AM
Oct 7, 2024 08:43AM
Oct 7, 2024 08:40AM
Oct 7, 2024 08:02AM Quantum BioPharma (QNTM) Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group
Oct 7, 2024 07:30AM

322,881 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All